Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Ethyol

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
PURPOSE The cytoprotective drug amifostine (Ethyol) protects rats from oral mucositis resulting from a single dose of gamma… Expand
Is this relevant?
2004
2004
Amifostine (Ethyol®) is a cytoprotective drug approved for the reduction of xerostomia in head and neck cancer when administered… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
Is this relevant?
Review
2003
Review
2003
The chemo- and radioprotectant drug amifostine (Ethyol; MedImmune, Inc, Gaithersburg, MD) is approved for intravenous (IV… Expand
Is this relevant?
2002
2002
Amifostine (Ethyol) has been evaluated clinically as a radioprotective agent for the prevention of xerostomia and mucositis for… Expand
Is this relevant?
2000
2000
Purpose: Amifostine (WR-2721), a phosphorylated aminothiol pro-drug which is an analogue of cysteamine, is a selective… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1997
1997
The main metabolites of the cytoprotective drug Ethyol (Amifostine, WR-2721) are the thiol WR-1065 and the disulphide WR-33278… Expand
Is this relevant?
Review
1996
Review
1996
Amifostine (Ethyol) administered to cancer patients is rapidly cleared from plasma by a biphasic decay with an alpha half-life… Expand
Is this relevant?
1996
1996
Cultured neonatal rat heart myocytes form a synchronously-contracting cell syncytium from one to two days after isolation… Expand
Is this relevant?
Review
1994
Review
1994
Amifostine (WR-2721, S-2 [3-aminopropylamino]-ethylphosphorothioic acid; Ethyol, US Bioscience, Inc. West Conshohocken, PA… Expand
Is this relevant?
1994
1994
This study investigated the metabolism of the radio- and chemoprotector compound, WR-2721 [amifostine; s-2-(3- aminopropylamino… Expand
Is this relevant?